MENU
VTYX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ventyx Biosciences (VTYX) Earnings Date & Reports

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders... Show more

A.I. Advisor
published Earnings

VTYX is expected to report earnings to rise 32.34% to -50 cents per share on November 12

Ventyx Biosciences VTYX Stock Earnings Reports
Q3'25
Est.
$-0.50
Q2'25
Beat
by $0.08
Q1'25
Beat
by $0.10
Q4'24
Beat
by $0.13
Q3'24
Beat
by $0.02
The last earnings report on August 07 showed earnings per share of -37 cents, beating the estimate of -46 cents. With 173.03K shares outstanding, the current market capitalization sits at 199.96M.
View a ticker or compare two or three
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VTYX showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
12790 El Camino Real
Phone
+1 760 593-4832
Employees
80
Web
https://www.ventyxbio.com